---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-020718"
form_type: "8-K"
ticker: "NSPR"
cik: "0001433607"
company_name: "InspireMD, Inc."
filed_at: "2025-11-04T23:59:59+00:00"
generated_at: "2026-05-17T00:35:52.242390+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# InspireMD Q3 revenue record $2.5M (+39% YoY) as U.S. CGuard Prime launch gains traction

## Summary
- U.S. revenue of $497k marks first commercial quarter for CGuard Prime carotid stent system.
- Net loss $12.7M ($0.17/share) vs $7.9M ($0.16) a year ago; operating expenses up 57% on U.S. expansion.
- Cash and marketable securities $63.4M at Sep 30, up from $34.6M at Dec 31, 2024, boosted by $58M July offering.
- Over 100 U.S. carotid procedures completed; appointed Peter A. Soukas, M.D. as CMO and Dan Dearen to board.
- Gross profit nearly doubled to $864k on favorable shift toward higher-margin U.S. sales.

## SEC filing metadata
- accession: 0001493152-25-020718
- form_type: 8-K
- ticker: NSPR
- cik: 0001433607
- company_name: InspireMD, Inc.
- filed_at: 2025-11-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1433607/000149315225020718/0001493152-25-020718-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1433607/000149315225020718/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-020718
- JSON: https://secwatch.observer/filing/0001493152-25-020718.json
- Plain text: https://secwatch.observer/filing/0001493152-25-020718.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.